Nisa Investment Advisors
CAI

Nisa Investment Advisors’s Caris Life Sciences CAI Stock Holding History

Nisa Investment Advisors’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$517 Sell
29
-393
-93% -$7.03K ﹤0.01% 2938
2026
Q1 		$7.54K Buy
+422
New +$9.22K ﹤0.01% 2336

Other funds holding CAI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $201M AUM
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SSP
Sixth Street Partners Dallas, Texas $579M AUM 2.46% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Nisa Investment Advisors's CAI Position: Q2 2026 in Review

Nisa Investment Advisors reduced its Caris Life Sciences (CAI) stake by 93% in Q2 2026, selling an estimated $7.03K and leaving 29 shares worth $517. The position accounts for ﹤0.01% of the portfolio, ranked #2938.

Nisa Investment Advisors first reported a position in CAI in Q1 2026 and has held it in 2 quarters since. The position peaked at $7.54K in Q1 2026. 247 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

  • Nisa Investment Advisors held 29 shares of Caris Life Sciences worth $517 as of Q2 2026.
  • Nisa Investment Advisors sold 393 Caris Life Sciences shares in Q2 2026, an estimated $7.03K.
  • Caris Life Sciences made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2938 holding.
  • Nisa Investment Advisors first reported a position in Caris Life Sciences in Q1 2026 and has held it in 2 quarters since.
  • Nisa Investment Advisors's Caris Life Sciences position peaked at $7.54K in Q1 2026.
  • 247 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.